# Tepezza & sensorineural hearing loss

> Hearing loss and tinnitus reported by some teprotumumab (Tepezza) patients treated for thyroid eye disease.

**Canonical URL:** https://drugsmonitor.com/injuries/tepezza-hearing-loss
**Last updated:** 2026-06-11

**Related cases:** https://drugsmonitor.com/case/tepezza-hearing-loss-lawsuit

Tepezza treats thyroid eye disease (Graves' ophthalmopathy). Post-marketing reports and litigation have alleged irreversible sensorineural hearing loss or tinnitus in some patients.

Audiology testing before and after treatment can document changes; FDA safety communications may evolve independently of private lawsuits.

Ophthalmology and ENT records are frequently discussed with counsel.

---

*Educational injury overview. Not medical advice.*